Acelrx Pharmaceuticals Inc Ret. on assets
What is the Ret. on assets of Acelrx Pharmaceuticals Inc?
The Ret. on assets of Acelrx Pharmaceuticals Inc is -74.46%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Acelrx Pharmaceuticals Inc
What does Acelrx Pharmaceuticals Inc do?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Companies with ret. on assets similar to Acelrx Pharmaceuticals Inc
- Angkor Resources has Ret. on assets of -74.64%
- Agenus Inc has Ret. on assets of -74.59%
- Verb Technology has Ret. on assets of -74.49%
- Sire Bioscience has Ret. on assets of -74.48%
- Odd Burger has Ret. on assets of -74.47%
- Globally Local Technologies has Ret. on assets of -74.47%
- Acelrx Pharmaceuticals Inc has Ret. on assets of -74.46%
- Odyssey Semiconductor Technologies has Ret. on assets of -74.43%
- CannaGrow has Ret. on assets of -74.40%
- Ennox Ltd has Ret. on assets of -74.39%
- Hoth Therapeutics has Ret. on assets of -74.38%
- Copper Lake Resources has Ret. on assets of -74.31%
- Ef funders Ventures Inc has Ret. on assets of -74.31%